With 12.94 million shares changed hands, the volume of the stock remained heavier than its average volume of 9.78 million shares. The 52-week range on NOVA shows that it touched its highest point at $13.00 and its lowest point at $1.85 during that stretch. It currently has a 1-year price target of $7.60. Beta for the stock currently stands at 2.59.
Price Performance and Earnings:
Three-month performance dropped to -48.64% while six-month performance fell -75.90%. The stock lost -82.63% in the past year, while it has lost -39.65% so far this year. A look at the trailing 12-month EPS for NOVA yields -3.35 with Next year EPS estimates of -2.28. For the next quarter, that number is -0.66. This implies an EPS growth rate of 34.14% for this year and 1.74% for next year. EPS is expected to grow by 18.03% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -17.44%.
Float and Shares Shorts:
At present, 124.92 million NOVA shares are outstanding with a float of 115.29 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NOVA since 15 analysts follow the stock currently. There are 9 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.85977 being high and -$3.17674 being low. For NOVA, this leads to a yearly average estimate of -$2.32249. Based on analyst estimates, the high estimate for the next quarter is -$0.55 and the low estimate is -$1.01. The average estimate for the next quarter is thus -$0.8.
